eCite Digital Repository

Echocardiographic evaluation of cardiac function after cancer chemotherapy


Negishi, T and Negishi, K, Echocardiographic evaluation of cardiac function after cancer chemotherapy, Journal of Echocardiography, 16, (1) pp. 20-27. ISSN 1349-0222 (2018) [Contribution to Refereed Journal]

Copyright Statement

© Japanese Society of Echocardiography 2017

DOI: doi:10.1007/s12574-017-0344-6


Progress in cancer therapy has led to improved prognosis of patients with cancer and thus to a continuous rise of cancer survivors. However, it has simultaneously increased cardiovascular morbidity and mortality rates due to direct and/or indirect side effects of anticancer treatment. Similar to the rapid rise of patients with adult congenital disease, the number of patients suffering or at risk of cardiotoxicity has been steeply increasing and getting an emerging issue. Among the many facets of chemotherapy-induced cardiovascular toxicity, this review attempts to summarize echocardiographic evaluation of cardiac function after cancer chemotherapy by reviewing the definition, risk factors, brief history, limitation of left ventricular ejection fraction and myocardial strain imaging, as well as the limitations of this technique.

Item Details

Item Type:Contribution to Refereed Journal
Keywords:anthracycline, cancer therapy-related cardiac dysfunction, cardiotoxicity, ejection fraction, myocardial strain, trastuzumab
Research Division:Biomedical and Clinical Sciences
Research Group:Cardiovascular medicine and haematology
Research Field:Cardiology (incl. cardiovascular diseases)
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Negishi, T (Dr Tomoko Negishi)
UTAS Author:Negishi, K (Dr Kazuaki Negishi)
ID Code:123880
Year Published:2018 (online first 2017)
Web of Science® Times Cited:3
Deposited By:Menzies Institute for Medical Research
Deposited On:2018-01-31
Last Modified:2018-12-13

Repository Staff Only: item control page